Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Phase Ib trial of gilteritinib in combination with mitoxantrone, cladribine, cytarabine and filgrastim (GM-CLAG) for relapsed/refractory FLT3-mutated acute myeloid leukemia
Qasrawi, Ayman
(PI)
Hildebrandt, Gerhard
(Former PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
1/17/22
→
10/30/23
Funding
Astellas Pharma Global Development Incorporated:
$30,000.00
View all
View less